Nemaura Medical Inc (FRA:N18A)

€ 0.115 0 (0%) Market Cap: 2.11 Mil Enterprise Value: 19.96 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Nemaura Medical Inc at Sidoti & Company November Virtual Micro-Cap Conference Transcript
Nov 15, 2023
Nemaura Medical Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Feb 22, 2023
Nemaura Medical Inc at Sidoti & Company January Micro-Cap Virtual Conference Transcript
Jan 19, 2023
Nemaura Medical Inc at Issuer Direct Planet MicroCap Showcase (Virtual) Transcript
Dec 07, 2022
Nemaura Medical Inc at Precious Metals Summit Planet Microcap Showcase Transcript
May 04, 2022
Nemaura Medical Inc at Benzinga Global Small Cap Investor Conference (Virtual) Transcript
Dec 08, 2021
Nemaura Medical Inc at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Sep 29, 2021
Nemaura Medical Inc at Benzinga Virtual Global Small Cap Conference Transcript
May 14, 2021
Nemaura Medical Inc Positive Results from Head-to-Head Study with Major CGM Call Transcript
May 10, 2020

Nemaura Medical Inc at Issuer Direct Planet MicroCap Showcase (Virtual) Transcript

Dec 07, 2022 / 02:00PM GMT

Transcript

Robert Kraft

Stock News Now - CEO

Welcome to the Planet MicroCap Showcase Virtual 2022. I'm your host, Robert Kraft. Thank you all for joining us. Now presenting at our event is Dr. Faz Chowdhury. He's the CEO of Nemaura Medical. Publicly traded company. And the symbol is NMRD on NASDAQ. Dr. Chowdhury take it away.

Faz Chowdhury

Nemaura Medical Inc. - CEO & Chairman

Thank you very much for the introduction.

And once again, thank you for inviting us to speak. And it's really a pleasure to be back here.

So today, I shall be giving you an update on the developments at the Nemaura Medical and as Robert mentioned I'm Faz Chowdhury, CEO of Nemaura Medical. And initially, just to highlight that I will be making some, I should be making some forward-looking statements. So, if you can just take a look at that slide for a moment there.

Okay, so let's dive straight into what is it, which what's the area, what's the market that we were addressing. So, when you look at the current, let's call it, the pandemic of diabetes, you've got

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.